Dismantling Exposure, Relaxation, and Rescripting Therapy
ERRT
Exposure, Relaxation, Rescripting Therapy (ERRT) Dismantling
1 other identifier
interventional
50
1 country
1
Brief Summary
The purpose of this case series dismantling study is to extend previous findings regarding the efficacy of a brief treatment for chronic post-trauma nightmares by examining the dose effect and mechanism of change. Exposure, relaxation, and rescripting therapy (ERRT) is a promising psychological intervention developed to target trauma-related nightmares and sleep disturbances. ERRT has exhibited strong support in reducing the frequency and intensity of nightmares, as well as improving overall sleep quality in both civilian and veteran samples. In addition, significant decreases in PTSD and depression symptoms have been reported following treatment (Davis et al., 2011; Davis \& Wright, 2007; Long et al., 2011; Swanson, Favorite, Horin, \& Arnedt, 2009). ERRT is currently an evidence-level B suggested treatment (Cranston, Davis, Rhudy, \& Favorite, 2011). Despite this evidence, the mechanism of change for ERRT remains unclear. We propose to conduct a set of case series in order to examine the possible mechanisms: psycho-education, dose response for exposure, and no exposure components of the treatment. Each part of the treatment is theorized to contribute to the improved treatment outcome and it is hypothesized that participants will benefit no matter what group they are in. All participants will receive 5 to 6 treatment sessions, conducted once per week for about 90 minutes, of a modified version of ERRT.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2014
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2014
CompletedFirst Submitted
Initial submission to the registry
September 8, 2014
CompletedFirst Posted
Study publicly available on registry
September 10, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2025
CompletedJuly 3, 2024
July 1, 2024
10.9 years
September 8, 2014
July 1, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Nightmare Frequency Past Week
This fill-in-the-blank variable assesses the number of nights the individual experienced nightmares in the past week (range = 0 - 7 nights). Higher values indicate more nights with nightmares (worse outcome).
up to 6 months followup
Study Arms (5)
ERRT - Enhanced Exposure
ACTIVE COMPARATORExposure, Relaxation, and Rescripting Therapy, 5 sessions, with enhanced exposure techniques
ERRT - Sleep and Relaxation
ACTIVE COMPARATORExposure, Relaxation, and Rescripting Therapy protocol, 5 sessions, focused on sleep and relaxation
ERRT-Rescription
ACTIVE COMPARATORExposure, Relaxation, and Rescripting Therapy, 5 sessions, with rescription but no exposure
ERRT-Sleep
ACTIVE COMPARATORExposure, Relaxation, and Rescripting Therapy, 5 sessions, with enhanced sleep techniques
ERRT - Consensus Manual
ACTIVE COMPARATORConsensus Protocol, 6 sessions, includes components of ERRT and other nightmare protocols.
Interventions
Brief cognitive behavioral treatment targeting trauma-related nightmares and sleep problems
Eligibility Criteria
You may qualify if:
- years of age or older at the time of the intake,
- experienced a traumatic event, as defined by the Diagnostic and Statistical Manual (DSM-5),
- have approximately one nightmare each week for the past month
- be able to read and speak English.
You may not qualify if:
- age of 17 or younger
- acute or apparent psychosis
- unmedicated bipolar disorder
- intellectual disability
- active suicidality,
- recent parasuicidal behaviors
- untreated substance use disorder in past 6 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Joanne L. Davis
Tulsa, Oklahoma, 74104, United States
Related Publications (1)
Davis JL, Rhudy JL, Pruiksma KE, Byrd P, Williams AE, McCabe KM, Bartley EJ. Physiological predictors of response to exposure, relaxation, and rescripting therapy for chronic nightmares in a randomized clinical trial. J Clin Sleep Med. 2011 Dec 15;7(6):622-31. doi: 10.5664/jcsm.1466.
PMID: 22171201BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Joanne L Davis, PhD
University of Tulsa
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NON RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
September 8, 2014
First Posted
September 10, 2014
Study Start
August 1, 2014
Primary Completion
July 1, 2025
Study Completion
August 1, 2025
Last Updated
July 3, 2024
Record last verified: 2024-07